Skip to main content

Table 5 Antibiotic susceptibilities of 32 MRSA isolates, stratified by CA-MRSA criteria

From: Clinical and microbiological characteristics of purulent and non-purulent cellulitis in hospitalized Taiwanese adults in the era of community-associated methicillin-resistant Staphylococcus aureus

Antibiotic No. (%) of samples, by susceptibility
Epidemiological classification
CA-MRSA (n = 22) Non CA-MRSA (n = 10) P-value
Chloramphenicol (%) 12 (54.5) 7 (70) 0.467
Clindamycin (%)a 4 (19) 0 (0) 0.287
Erythromycin (%) 4 (18.2) 0 (0) 0.283
Minocycline (%) 20 (95.2) 8 (80) 0.237
Levofloxacin (%) 18 (81.8) 5 (50) 0.096
Rifampin (%) 22 (100) 8 (80) 0.091
TMP-SMX (%) 21 (95.5) 7 (70) 0.079
Vancomycin (%) 22 (100) 10 (100) 1.000
  1. Data are number (%) of patients, unless otherwise indicated
  2. TMP-SMX trimethoprim-sulfamethoxazole
  3. aSusceptibility to clindamycin was determined for 21 CA-MRSA isolates and nine non-CA-MRSA isolates. The D-test was performed to detect inducible clindamycin resistance for isolates found to be resistant to erythromycin, but susceptible to clindamycin